Effects of pioglitazone and linagliptin on glycemic control, lipid profile and hs-CRP in metformin-treated patients with type 2 diabetes: a comparative study.

Batool ZamaniSeyyed Mashaalah TabatabizadehHamidreza GilasiShadi Yazdani

Published in: Hormone molecular biology and clinical investigation (2023)

The present study demonstrated the superiority of linagliptin over pioglitazone for glycemic control, although pioglitazone compared to linagliptin showed greater efficacy in reducing triglycerides and raising HDL-cholesterol.

Keyphrases

glycemic control
type diabetes
blood glucose
weight loss
insulin resistance
adipose tissue
skeletal muscle
low density lipoprotein